Addressing overtreatment of screen detected DCIS; the LORIS trial-Reference-Cited by-同舟云学术

Addressing overtreatment of screen detected DCIS; the LORIS trial

Published:2015-11 Issue:16 Volume:51 Page:2296-2303
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Francis Adele,Thomas Jeremy,Fallowfield Lesley,Wallis Matthew,Bartlett John M.S.,Brookes Cassandra,Roberts Tracy,Pirrie Sarah,Gaunt Claire,Young Jennie,Billingham Lucinda,Dodwell David,Hanby Andrew,Pinder Sarah E.,Evans Andrew,Reed Malcolm,Jenkins Valerie,Matthews Lucy,Wilcox Maggie,Fairbrother Patricia,Bowden Sarah,Rea Daniel^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Independent, U.K.P.O.B.C.S., The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380(9855): p. 1778–86.

2. Cancer detection: breast-screening trials are ethical;Biller-Andorno;Nature,2014

3. The breast screening programme and misinforming the public;Gotzsche;J R Soc Med,2011

4. Mammographic screening and “overdiagnosis”;Kopans;Radiology,2011

5. CRUKwebsite, .

Cited by 295 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome;Breast Cancer Research;2024-09-02

2. Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives;Japanese Journal of Clinical Oncology;2024-09-02

3. Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis;Breast Cancer Research and Treatment;2024-08-24

4. Ductal Carcinoma In Situ;Hematology/Oncology Clinics of North America;2024-08

5. Potential Overtreatment of DCIS in Patients with Limited Life Expectancy;Annals of Surgical Oncology;2024-07-20